Skip to main content
Miguel Perales, MD, Oncology, New York, NY

MiguelAPeralesMD

Oncology • New York, NY

Chief, Adult BMT Service, Memorial Sloan Kettering Cancer Center

Request Appointment

Overview of Dr. Perales

Dr. Miguel Perales is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Universite Libre de Bruxelles Faculty of Medicine and has been in practice 26 years. Dr. Perales accepts several types of health insurance, listed below. He is one of 503 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He also speaks multiple languages, including Spanish, Dutch, French, and German. He has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 1995 - 1998
  • Universite Libre de Bruxelles Faculty of Medicine
    Universite Libre de Bruxelles Faculty of MedicineClass of 1991

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • CT State Medical License
    CT State Medical License 2023 - 2026
  • NY State Medical License
    NY State Medical License 1998 - 2025
  • NC State Medical License
    NC State Medical License 2021 - 2022
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma
    Miguel-Angel Perales, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 10th, 2022
  • Omeros Corporation Reports Third Quarter 2020 Financial Results
    Omeros Corporation Reports Third Quarter 2020 Financial ResultsNovember 9th, 2020
  • Omeros Reports Final Efficacy and Safety Data from the Narsoplimab Pivotal Trial in HSCT-TMA
    Omeros Reports Final Efficacy and Safety Data from the Narsoplimab Pivotal Trial in HSCT-TMAOctober 22nd, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish, Dutch, French, German

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Miguel Perales, Dr. Miguel Perales, MD, Dr. M Perales, Dr. Miguel A Perales